TABLE 1.
Demographic and clinical characteristics of study participants.
Patients | Total (n = 4913) | AD (n = 3372) | DLB (n = 360) | FTD (n = 415) | VD (n = 766) |
Age (years, mean ± SD) | 78.3 ± 8.2 | 78.3 ± 8.0 | 78 ± 7.3 | 72.3 ± 8.9 | 81.6 ± 7.0 |
Sex (female, %) | 59.7 | 63.5 | 42.2 | 46.7 | 58.4 |
Duration of the disease (years, mean ± SD) | 4.5 ± 3.1 | 4.6 ± 3.1 | 4.5 ± 3 | 4.8 ± 3.2 | 4.1 ± 2.9 |
Regional distribution | |||||
North (%) | 32.2 | 26.5 | 35.3 | 47.5 | 47.8 |
Centre (%) | 31.5 | 34.1 | 36.4 | 21.2 | 23.4 |
South - Islands (%) | 36.3 | 39.4 | 28.3 | 31.3 | 28.8 |
CDR Stage (%) | |||||
1 | 25.0 | 24.3 | 26.3 | 23.4 | 28.4 |
2 | 47.8 | 49.2 | 41.9 | 48.6 | 43.8 |
3 | 27.2 | 26.5 | 31.8 | 28.0 | 27.8 |
Duration of the quarantine (days, mean ± SD) | 47.2 ± 6.4 | 47.2 ± 6.5 | 46.6 ± 5.6 | 46.4 ± 5.3 | 47.8 ± 6.8 |
Changes in cognitive symptoms (Yes, %) | 55.1 | 55.7 | 59.6 | 48.3 | 54.2 |
Sex (female, %) | 58.4 | 63.0 | 36.3 | 44.7 | 55.2 |
Changes in BPSD (Yes, %) | 51.9 | 50.5 | 63.8 | 55.3 | 50.3 |
Sex (female, %) | 57.9 | 62.9 | 38.4 | 45.4 | 55.1 |
New onset BPSD (Yes, %) | 25.9 | 26.7 | 23.3 | 21.9 | 25.6 |
Sex (female, %) | 56.7 | 59.8 | 41.7 | 41.8 | 56.1 |
Changes in motor symptoms (Yes, %) | 36.7 | 33.2 | 52.8 | 40.2 | 42.3 |
Sex (female, %) | 58.6 | 65.0 | 44.7 | 43.1 | 52.5 |
Caregivers | |||||
Age (years, mean ± SD) | 59.3 ± 13 | 59.3 ± 13.1 | 60.7 ± 12.7 | 59.1 ± 13.6 | 60 ± 12.4 |
Sex (female, %) | 53.9 | 51.2 | 66.4 | 55.4 | 59.4 |
Cohabitant caregiver (%) | 58.9 | 58.1 | 63.5 | 69.6 | 54.4 |
Degree of kinship | |||||
Spouses (%) | 36.0 | 35.0 | 43.1 | 54.8 | 26.9 |
Son/daughter (%) | 54.5 | 55.5 | 48.7 | 37 | 62.5 |
Others (%) | 9.5 | 9.5 | 8.2 | 8.2 | 10.6 |
Increase in anxiety (%) | 45.9 | 46.1 | 43.4 | 44.2 | 47.4 |
Increase in depression (%) | 18.6 | 17.2 | 21.3 | 24.3 | 20.3 |
AD, Alzheimer’s disease; DLB, Dementia with Lewy Bodies; FTD, frontotemporal dementia; VD, vascular dementia; CDR, Clinical Dementia Rating; BPSD, Behavioral and Psychological symptoms of dementia.